A Follow-up Study With Children Who Participated in the TEMPO Study in Their First Year of Life

Last updated: December 4, 2023
Sponsor: Nutricia Research
Overall Status: Active - Recruiting

Phase

N/A

Condition

Allergy

Allergies & Asthma

Allergy (Pediatric)

Treatment

Self-administered questionnaires

Clinical Study ID

NCT05449756
EBB18TA23570
  • Ages 3-10
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

This is a follow-up study of a randomised clinical trial, called TEMPO (a double-blind randomized clinical trial investigating infant formula and human breast milk consumption), in which infants participated in their first year of life. The investigators like to know if these children develop allergies or infections in childhood and whether their feeding pattern in infancy plays a role.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Subjects are eligible to participate in the TEMPO Follow-Up study in case:
  • they completed the final (12 months) visit in the TEMPO study.
  • parents agree that their contact details will be shared with a third party for studypurposes.
  • parents agree that data collected in the TEMPO study will be used in the TEMPOFollow-Up study.
  • parents provide written informed consent for participation in the TEMPO Follow-Up inaccordance with local law.

Exclusion

Exclusion Criteria:

  • Parents who do not have a smartphone, tablet or personal computer with internetaccess.

Study Design

Total Participants: 705
Treatment Group(s): 1
Primary Treatment: Self-administered questionnaires
Phase:
Study Start date:
May 30, 2023
Estimated Completion Date:
March 31, 2029

Connect with a study center

  • PreCare Trial & Recruitment

    Beek, 6191 JW
    Netherlands

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.